We will be reviewing a real-world situation impacting the State of Delaware's self funded insurance plan and their health plan members. Costs are rising due to some extent by Ozempic and as expected premium cost increases are under consideration.
The article may be accessed at: https://www.delawarepublic.org/politics-government/2024-07-22/delaware-paid-over-12-million-more-on-weight-loss-drugs-than-expected-trend-increases-to-follow
The body in charge of state employee health insurance plans prepares to vote on new trend increases after ending the year in a $10 million deficit.
Please connect with me at: rkm2103@cumc.columbia.edu
follow me on X: @KentMcKinney
LinkedIn: www.linkedin.com/in/mckinneykent